Evaluation of CRP, D-Dimer of clinical significance in Iraqi patients with COVID-19 and associated comorbidities
Keywords:
COVID-19, CRP, D-dimer, diabetes, hypertensionAbstract
Background: The pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an unprecedented global social and economic impact, and high numbers of deaths. Many risk factors have been identified in the progression of COVID-19 into a severe and critical stage, underlying comorbidities such as hypertension, diabetes, obesity, chronic lung diseases, heart, liver and kidney diseases. Aims and Methods: This study was designed to investigate Measurement of serum C-reactive protein( CRP) level, plasma D-dimer level and evaluate the levels of each one of the studied parameters between patients infected by coronavirus COVID-19 and no associated comorbidities and patients infected by coronavirus COVID-19 with associated comorbidity (Diabetes , Hypertension). Results: The mean of CRP was 19.31 ± 8.205 in control, , 96.80 ± 18.33 in HTN, 51.08 ± 16.56 in DM group, while mean of D-dimer was 560.45 ± 155.13 in control group, , 1178.86 ± 379.12 in HTN group, 1529.51 ± 530.20 in DM group of patients.
Downloads
References
Andina T, Tampubolon DJ. 54. COMPARATION OF D-DIMER LEVELS IN HYPERTENSIVE AND NON-HYPERTENSIVE ADULT COVID-19 PATIENTS. Journal of Hypertension. 2021 May 1;39:e14.
Azevedo RB, Botelho BG, Hollanda JVG, Ferreira LVL, Junqueira de Andrade LZ, Oei SSML, Mello TS, Muxfeldt ES. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021 Jan;35(1):4-11. doi: 10.1038/s41371-020-0387-4. Epub 2020 Jul 27. PMID: 32719447; PMCID: PMC7384729.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020 Feb 15;395(10223):507-13.
Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. China cardiovasculardiseases report 2018: an updated summary. J Geriatr Cardiol 2020;17(1):1–8,http://dx.doi.org/10.11909/j.issn.1671-5411.2020.01.001.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A. COVID-19 and cardiovascular disease. Circulation. 2020 May 19;141(20):1648-55.
Conte G, Cei M, Evangelista I, Colombo A, Vitale J, Mazzone A, Mumoli N. The meaning of D-Dimer value in Covid-19. Clinical and Applied Thrombosis/Hemostasis. 2021 May 23;27:10760296211017668.
Das S, Anu KR, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Life sciences. 2020 Oct 1;258:118202.
De Vito A, Fiore V, Princic E, Geremia N, Panu Napodano CM, Muredda AA, Maida I, Madeddu G, Babudieri S. Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS One. 2021 Mar 16;16(3):e0248009.
Debi H, Itu ZT, Amin MT, Hussain F, Hossain MS. Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis. Expert Review of Endocrinology & Metabolism. 2022 Jan 2;17(1):83-93.
Erener S. Diabetes, infection risk and COVID-19. Molecular metabolism. 2020 Sep 1;39:101044.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and dia-betes mellitus at increased risk for COVID-19 infection? Lancet Respir Med2020;8(4):e21, http://dx.doi.org/10.1016/s2213-2600(20)30116-8.
Fernandez C, Rysa J, Almgren P, Nilsson J, Engstrom G, Orho-Melander M, et al.Plasma levels of the proprotein convertase furin and incidence of diabetes andmortality. J Intern Med 2018;284(4):377–87,
Han H, Yang L, Liu R, Liu F, Wu KL, Li J, Liu XH, Zhu CL. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical Chemistry and Laboratory Medicine (CCLM). 2020 Jul 1;58(7):1116-20.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15;395(10223):497-506.
Kamel AH, Basuoni A, Salem ZA, AbuBakr N. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. British dental journal. 2021 Feb 24:1-7.
Khan M, Singh GK, Abrar S, Ganeshan R, Morgan K, Harky A. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert opinion on pharmacotherapy. 2021 Dec 12;22(18):2455-74.
Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858
Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Comorbid diabetes resultsin immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight 2019;4(20):e131774,
Osman S, E.G., 2022. Assessment of D. Dimer in Sudanese Patients with COVID19 in Khartoum State 2021. EC Microbiology, 18, pp.04-10.
Qeadan F, Tingey B, Gu LY, Packard AH, Erdei E, Saeed AI. Prognostic values of serum ferritin and D-dimer trajectory in patients with COVID-19. Viruses. 2021 Mar;13(3):419.
Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally relatedto expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian ran-domization analysis highlights tentative relevance of diabetes-related traits.Diabetes Care 2020;2020:dc200643.
Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, Moudi E, Rostami A, Barary M, Hosseini A, Bijani A. C-reactive protein as a prognostic indicator in COVID-19 patients. Interdisciplinary Perspectives on Infectious Diseases. 2021 Apr 23;2021.
Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19.Am J Hypertens 2020;33(5):373–4, http://dx.doi.org/10.1093/ajh/hpaa057
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanismsof SARS-CoV-2. Proc Natl Acad Sci U S A 2020;117(21):11727–34,
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis. 2020 May;18(5):1094-9.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of138 hospitalized patients with 2019 novel coronavirus-infected pneumoniain Wuhan, China. JAMA 2020;323(11):1061–9, http://dx.doi.org/10.1001/jama.2020.1585.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Mar 17;323(11):1061-9.
WHO Q&A on coronaviruses (COVID-19) March (2020). https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
World Health Organization. Living guidance for clinical management of COVID-19: living guidance, 23 November 2021. World Health Organization; 2021.
Yang Q, Zhou Y, Wang X, Gao S, Xiao Y, Zhang W, Hu Y, Wang Y. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis. Respiratory research. 2020 Dec;21(1):1-9.
Zeng X, Rathinasabapathy A, Liu D, Zha L, Liu X, Tang Y, Li F, Lin W, Yu Z, Chen H. Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China. Scientific reports. 2021 Nov 17;11(1):1-0.
Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current biology. 2020 Apr 6;30(7):1346-51.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature reviews cardiology. 2020 May;17(5):259-60.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection. 2020 Aug 1;81(2):e16-25.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factorsfor mortality of adult inpatients with COVID-19 in Wuhan, China: a retro-spective cohort study. Lancet 2020;395(10229):1054–62,
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
